Consistent with the bioinformatic data, CPS1 protein levels in TP53‐mutant tumor tissues were also considerably elevated compared with those in TP53‐wild‐type tumor tissues in BC patients (Figure 1e). This evidence concerns the gene TP53 and breast cancer.